Somatostatin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database

Somatostatin (somatotropin release inhibiting factor) is an abundant neuropeptide, which acts on five subtypes of somatostatin receptor (SST1-SST5; nomenclature as agreed by the NC-IUPHAR Subcommittee on Somatostatin Receptors [89]). Activation of these receptors produces a wide range of physiological effects throughout the body including the inhibition of secretion of many hormones. Endogenous ligands for these receptors are somatostatin-14 (SRIF-14) and somatostatin-28 (SRIF-28). cortistatin-14 has also been suggested to be an endogenous ligand for somatostatin receptors [56].

[1]  M. Korbonits,et al.  International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature , 2018, Pharmacological Reviews.

[2]  S. Schulz,et al.  Phosphorylation of threonine 333 regulates trafficking of the human sst5 somatostatin receptor. , 2013, Molecular endocrinology.

[3]  S. Schulz,et al.  Correlation of monoclonal and polyclonal somatostatin receptor 5 antibodies in pancreatic neuroendocrine tumors. , 2013, International journal of clinical and experimental pathology.

[4]  S. Schulz,et al.  Reassessment of sst3 Somatostatin Receptor Expression in Human Normal and Neoplastic Tissues Using the Novel Rabbit Monoclonal Antibody UMB-5 , 2012, Neuroendocrinology.

[5]  A. Colao,et al.  A 12-month phase 3 study of pasireotide in Cushing's disease. , 2012, The New England journal of medicine.

[6]  D. Treit,et al.  The anxiolytic effects of somatostatin following intra-septal and intra-amygdalar microinfusions are reversed by the selective sst2 antagonist PRL2903 , 2012, Pharmacology Biochemistry and Behavior.

[7]  H. M. Morris,et al.  Lamina- and cell-specific alterations in cortical somatostatin receptor 2 mRNA expression in schizophrenia , 2012, Neuropharmacology.

[8]  M. Buchfelder,et al.  DG3173 (somatoprim), a unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reduces GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours. , 2012, European journal of endocrinology.

[9]  S. Lamberts,et al.  Immunohistochemical localization and quantitative expression of somatostatin receptors in normal human spleen and thymus: Implications for the in vivo visualization during somatostatin receptor scintigraphy , 2012, Journal of Endocrinological Investigation.

[10]  S. Schulz,et al.  A Switch of G Protein-Coupled Receptor Binding Preference from Phosphoinositide 3-Kinase (PI3K)–p85 to Filamin A Negatively Controls the PI3K Pathway , 2011, Molecular and Cellular Biology.

[11]  E. Sztul,et al.  Endosomal trafficking of the G protein-coupled receptor somatostatin receptor 3. , 2011, Biochemical and biophysical research communications.

[12]  Wolfgang A Weber,et al.  PET of Somatostatin Receptor–Positive Tumors Using 64Cu- and 68Ga-Somatostatin Antagonists: The Chelate Makes the Difference , 2011, The Journal of Nuclear Medicine.

[13]  J. Reubi,et al.  Somatostatin Receptors as Targets for Nuclear Medicine Imaging and Radionuclide Treatment , 2011, The Journal of Nuclear Medicine.

[14]  J. Brandner,et al.  Somatostatin Inhibits Cell Migration and Reduces Cell Counts of Human Keratinocytes and Delays Epidermal Wound Healing in an Ex Vivo Wound Model , 2011, PloS one.

[15]  M. Ghosh,et al.  Ligand-dependent mechanisms of sst2A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists. , 2011, Molecular endocrinology.

[16]  M. Ghosh,et al.  Differential Temporal and Spatial Regulation of Somatostatin Receptor Phosphorylation and Dephosphorylation* , 2011, The Journal of Biological Chemistry.

[17]  K. Jurkschat,et al.  One-step ¹⁸F-labeling of carbohydrate-conjugated octreotate-derivatives containing a silicon-fluoride-acceptor (SiFA): in vitro and in vivo evaluation as tumor imaging agents for positron emission tomography (PET). , 2010, Bioconjugate chemistry.

[18]  J. Kittilson,et al.  Rainbow trout somatostatin receptor subtypes SSTR1A, SSTR1B, and SSTR2 differentially activate the extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling pathways in transfected cells. , 2010, Journal of molecular endocrinology.

[19]  J. Reubi,et al.  Radiolabeled Bicyclic Somatostatin-Based Analogs: A Novel Class of Potential Radiotracers for SPECT/PET of Neuroendocrine Tumors , 2010, The Journal of Nuclear Medicine.

[20]  D. Corella,et al.  The rs1466113 Polymorphism in the Somatostatin Receptor 2 Gene Is Associated with Obesity and Food Intake in a Mediterranean Population , 2010, Annals of Nutrition and Metabolism.

[21]  Lei Wang,et al.  Selective central activation of somatostatin receptor 2 increases food intake, grooming behavior and rectal temperature in rats. , 2010, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[22]  E. Christ,et al.  Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patients. , 2010, The Journal of clinical endocrinology and metabolism.

[23]  J. Epelbaum,et al.  Somatostatin Contributes to In Vivo Gamma Oscillation Modulation and Odor Discrimination in the Olfactory Bulb , 2010, The Journal of Neuroscience.

[24]  M. Buchfelder,et al.  The somatostatin analogue octreotide confers sensitivity to rapamycin treatment on pituitary tumor cells. , 2010, Cancer research.

[25]  J. Rivier,et al.  Agonist-biased signaling at the sst2A receptor: the multi-somatostatin analogs KE108 and SOM230 activate and antagonize distinct signaling pathways. , 2010, Molecular endocrinology.

[26]  A. Faggiano,et al.  Somatostatin analogues: treatment of pituitary and neuroendocrine tumors. , 2010, Progress in brain research.

[27]  M. Culler,et al.  Differential efficacy of SSTR1, -2, and -5 agonists in the inhibition of C6 glioma growth in nude mice. , 2009, American journal of physiology. Endocrinology and metabolism.

[28]  P. Rochaix,et al.  Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer , 2009, Proceedings of the National Academy of Sciences.

[29]  C. Schade-Brittinger,et al.  Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  S. Schulz,et al.  Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors. , 2009, The Journal of clinical endocrinology and metabolism.

[31]  A. Schonbrunn,et al.  Site Specificity of Agonist and Second Messenger-Activated Kinases for Somatostatin Receptor Subtype 2A (Sst2A) Phosphorylation , 2009, Molecular Pharmacology.

[32]  J. Reubi,et al.  Highly Efficient In Vivo Agonist-Induced Internalization of sst2 Receptors in Somatostatin Target Tissues , 2009, Journal of Nuclear Medicine.

[33]  C. Verney,et al.  The Somatostatin 2A Receptor Is Enriched in Migrating Neurons during Rat and Human Brain Development and Stimulates Migration and Axonal Outgrowth , 2009, PloS one.

[34]  S. Schulz,et al.  Differential effects of octreotide and pasireotide on somatostatin receptor internalization and trafficking in vitro. , 2009, The Journal of clinical endocrinology and metabolism.

[35]  S. Schulz,et al.  Interaction of the human somatostatin receptor 3 with the multiple PDZ domain protein MUPP1 enables somatostatin to control permeability of epithelial tight junctions , 2009, FEBS letters.

[36]  D. Figarella-Branger,et al.  Somatostatin receptor sst2 decreases cell viability and hormonal hypersecretion and reverses octreotide resistance of human pituitary adenomas. , 2008, Cancer research.

[37]  S. Najib,et al.  Phosphatidylinositol 3-kinase-dependent transcriptional silencing of the translational repressor 4E-BP1 , 2008, Cellular and Molecular Life Sciences.

[38]  M. Culler,et al.  Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2. , 2008, Endocrinology.

[39]  Jean E Rivier,et al.  Design and in vitro characterization of highly sst2-selective somatostatin antagonists suitable for radiotargeting. , 2008, Journal of medicinal chemistry.

[40]  F. Lopez,et al.  Identification of an upstream promoter of the human somatostatin receptor, hSSTR2, which is controlled by epigenetic modifications. , 2008, Endocrinology.

[41]  M. Culler,et al.  Efficacy of a dopamine-somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study. , 2008, Endocrine-related cancer.

[42]  M. Strowski,et al.  Function and expression of somatostatin receptors of the endocrine pancreas , 2008, Molecular and Cellular Endocrinology.

[43]  M. Buchfelder,et al.  Selective loss of somatostatin receptor 2 in octreotide-resistant growth hormone-secreting adenomas. , 2008, The Journal of clinical endocrinology and metabolism.

[44]  S. Schulz,et al.  New Pansomatostatin Ligands and Their Chelated Versions: Affinity Profile, Agonist Activity, Internalization, and Tumor Targeting , 2008, Clinical Cancer Research.

[45]  S. Schulz,et al.  Indium-111-pentetreotide scintigraphy and somatostatin receptor subtype 2 expression: new prognostic factors for malignant well-differentiated endocrine tumors. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[46]  I. Sauer,et al.  Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition. , 2007, Endocrinology.

[47]  P. Bagnoli,et al.  Antiangiogenic role of somatostatin receptor 2 in a model of hypoxia-induced neovascularization in the retina: results from transgenic mice. , 2007, Investigative ophthalmology & visual science.

[48]  H. Parkington,et al.  Somatostatin decreases voltage-gated Ca2+ currents in GH3 cells through activation of somatostatin receptor 2. , 2007, American journal of physiology. Endocrinology and metabolism.

[49]  A. Balbarini,et al.  Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages , 2007, Journal of leukocyte biology.

[50]  B. Wiedenmann,et al.  Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets. , 2007, The Journal of clinical endocrinology and metabolism.

[51]  D. lattuada,et al.  Inhibitory effect of pasireotide and octreotide on lymphocyte activation , 2007, Journal of Neuroimmunology.

[52]  R. Baum,et al.  Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[53]  Frédéric Lopez,et al.  Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway , 2006, The EMBO journal.

[54]  A. Bottoni,et al.  Role of complex cyclin d1/cdk4 in somatostatin subtype 2 receptor-mediated inhibition of cell proliferation of a medullary thyroid carcinoma cell line in vitro. , 2006, Endocrinology.

[55]  U. Pagotto,et al.  Octreotide, a somatostatin analogue, mediates its antiproliferative action in pituitary tumor cells by altering phosphatidylinositol 3-kinase signaling and inducing Zac1 expression. , 2006, Cancer research.

[56]  B. Bernard,et al.  [(99m)Tc]Demotate 2 in the detection of sst(2)-positive tumours: a preclinical comparison with [(111)In]DOTA-tate. , 2006, European journal of nuclear medicine and molecular imaging.

[57]  Y. Wong,et al.  Activation of nuclear factor {kappa}B by somatostatin type 2 receptor in pancreatic acinar AR42J cells involves G{alpha}14 and multiple signaling components: a mechanism requiring protein kinase C, calmodulin-dependent kinase II, ERK, and c-Src. , 2005, The Journal of biological chemistry.

[58]  L. Pradayrol,et al.  Characterization of the bystander effect of somatostatin receptor sst2 after in vivo gene transfer into human pancreatic cancer cells. , 2005, Human gene therapy.

[59]  J. Rivier,et al.  Receptor Signaling and Endocytosis Are Differentially Regulated by Somatostatin Analogs , 2005, Molecular Pharmacology.

[60]  S. Yibchok-anun,et al.  Somatostatin Increases Phospholipase D Activity and Phosphatidylinositol 4,5-bisphosphate Synthesis in Clonal β Cells HIT-T15 , 2005, Molecular Pharmacology.

[61]  P. Rochaix,et al.  Octreotide in insulinoma patients: efficacy on hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. , 2005, European journal of endocrinology.

[62]  S. Atkin,et al.  Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium , 2005, British Journal of Cancer.

[63]  Martin A Walter,et al.  Preclinical evaluation of new and highly potent analogues of octreotide for predictive imaging and targeted radiotherapy. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[64]  J. Rivier,et al.  Somatostatin receptor 1 selective analogues: 3. Dicyclic peptides. , 2005, Journal of medicinal chemistry.

[65]  Kamel El-Darwish,et al.  Superagonism at the Human Somatostatin Receptor Subtype 4 , 2005, Journal of Pharmacology and Experimental Therapeutics.

[66]  D. Hoyer,et al.  Somatostatin receptor 1 selective analogues: 2. N(alpha)-Methylated scan. , 2005, Journal of medicinal chemistry.

[67]  S. Arena,et al.  Somatostatin receptor subtype-dependent regulation of nitric oxide release: involvement of different intracellular pathways. , 2005, Molecular Endocrinology.

[68]  M. Low.  Clinical endocrinology and metabolism. The somatostatin neuroendocrine system: physiology and clinical relevance in gastrointestinal and pancreatic disorders. , 2004, Best practice & research. Clinical endocrinology & metabolism.

[69]  V. Martínez,et al.  Role of somatostatin receptors on gastric acid secretion in wild-type and somatostatin receptor type 2 knockout mice , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[70]  P. Bagnoli,et al.  Functional correlates of somatostatin receptor 2 overexpression in the retina of mice with genetic deletion of somatostatin receptor 1 , 2004, Brain Research.

[71]  H. Schmid,et al.  Functional Activity of the Multiligand Analog SOM230 at Human Recombinant Somatostatin Receptor Subtypes Supports Its Usefulness in Neuroendocrine Tumors , 2004, Neuroendocrinology.

[72]  S. Atkin,et al.  Inhibition of endothelial proliferation by the somatostatin analogue SOM230 , 2004, Clinical endocrinology.

[73]  A. Kappeler,et al.  Cellular detection of sst2A receptors in human gastrointestinal tissue , 2004, Gut.

[74]  R. Murray,et al.  Central and peripheral actions of somatostatin on the growth hormone-IGF-I axis. , 2004, The Journal of clinical investigation.

[75]  M. Norman,et al.  Deficiency of somatostatin (SST) receptor type 5 (SSTR5) is associated with sexually dimorphic changes in the expression of SST and SST receptors in brain and pancreas , 2004, Molecular and Cellular Endocrinology.

[76]  P. Dasgupta.  Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis. , 2004, Pharmacology & therapeutics.

[77]  C. Bousquet,et al.  Molecular Signaling of Somatostatin Receptors , 2004, Annals of the New York Academy of Sciences.

[78]  K. Thermos,et al.  The somatostatin receptor (sst1) modulates the release of somatostatin in rat retina , 2004, Neuroscience Letters.

[79]  P. Bagnoli,et al.  Altered morphology of rod bipolar cell axonal terminals in the retinas of mice carrying genetic deletion of somatostatin subtype receptor 1 or 2 , 2004, The European journal of neuroscience.

[80]  T. Troxler,et al.  SRA880, in vitro characterization of the first non-peptide somatostatin sst(1) receptor antagonist. , 2004, Neuroscience letters.

[81]  I. Shimon,et al.  PTR-3173 (Somatoprim™), a novel somatostatin analog with affinity for somatostatin receptors 2, 4 and 5 is a potent inhibitor of human GH secretion , 2004, Journal of endocrinological investigation.

[82]  J. Reubi,et al.  In vivo phosphorylation of the somatostatin 2A receptor in human tumors. , 2003, The Journal of clinical endocrinology and metabolism.

[83]  J. Rivier,et al.  Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan. , 2003, Journal of medicinal chemistry.

[84]  M. Cattaneo,et al.  Anti-migratory and Anti-invasive Effect of Somatostatin in Human Neuroblastoma Cells , 2003, Journal of Biological Chemistry.

[85]  A. Eychène,et al.  sst2 Somatostatin Receptor Inhibits Cell Proliferation through Ras-, Rap1-, and B-Raf-dependent ERK2 Activation* , 2003, Journal of Biological Chemistry.

[86]  S. Melmed,et al.  Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion. , 2003, The Journal of clinical endocrinology and metabolism.

[87]  Eric Vivier,et al.  Critical role of Src and SHP-2 in sst2 somatostatin receptor-mediated activation of SHP-1 and inhibition of cell proliferation. , 2003, Molecular biology of the cell.

[88]  B. Bernard,et al.  DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labelling with various radiometals , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[89]  E. Woltering.  Development of targeted somatostatin-based antiangiogenic therapy: a review and future perspectives. , 2003, Cancer biotherapy & radiopharmaceuticals.

[90]  J. Reubi.  Peptide receptors as molecular targets for cancer diagnosis and therapy. , 2003, Endocrine reviews.

[91]  K. Kendrick,et al.  Somatostatin receptor 2 knockout/lacZ knockin mice show impaired motor coordination and reveal sites of somatostatin action within the striatum , 2003, The European journal of neuroscience.

[92]  S. Doublier,et al.  Somatostatin binds to murine macrophages through two distinct subsets of receptors , 2003, Journal of Neuroimmunology.

[93]  D. Coy,et al.  Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. , 2003, Diabetes.

[94]  N. LaRusso,et al.  Somatostatin stimulates ductal bile absorption and inhibits ductal bile secretion in mice via SSTR2 on cholangiocytes. , 2003, American journal of physiology. Cell physiology.

[95]  O. Lichtarge,et al.  Conserved Motifs in Somatostatin, D2-dopamine, and α2B-Adrenergic Receptors for Inhibiting the Na-H Exchanger, NHE1* , 2003, The Journal of Biological Chemistry.

[96]  D. Hoyer,et al.  Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists. , 2003, European journal of pharmacology.

[97]  D. Noonan,et al.  Somatostatin inhibits tumor angiogenesis and growth via somatostatin receptor-3-mediated regulation of endothelial nitric oxide synthase and mitogen-activated protein kinase activities. , 2003, Endocrinology.

[98]  D. Hoyer,et al.  Beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptide derivatives as potent agonists at somatostatin sst(4) receptors. , 2003, Naunyn-Schmiedeberg's archives of pharmacology.

[99]  H. Wilkinson,et al.  Somatostatin receptor subtype 5 regulates insulin secretion and glucose homeostasis. , 2003, Molecular endocrinology.

[100]  P. Rochaix,et al.  Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[101]  P. Emson,et al.  Identification of cells expressing somatostatin receptor 2 in the gastrointestinal tract of Sstr2 knockout/lacZ knockin mice , 2002, The Journal of comparative neurology.

[102]  J. Reubi,et al.  A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors. , 2002, European journal of pharmacology.

[103]  S. Lamberts,et al.  Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes. , 2002, American journal of physiology. Endocrinology and metabolism.

[104]  L. Pradayrol,et al.  Antitumor effect of in vivo somatostatin receptor subtype 2 gene transfer in primary and metastatic pancreatic cancer models. , 2002, Cancer research.

[105]  T. Murayama,et al.  Antisecretory effect of somatostatin on gastric acid via inhibition of histamine release in isolated mouse stomach. , 2002, European journal of pharmacology.

[106]  P. Dutar,et al.  Somatostatin receptor subtypes 2 and 4 affect seizure susceptibility and hippocampal excitatory neurotransmission in mice , 2002, The European journal of neuroscience.

[107]  J. Reubi,et al.  NODAGATOC, a new chelator-coupled somatostatin analogue labeled with [67/68Ga] and [111In] for SPECT, PET, and targeted therapeutic applications of somatostatin receptor (hsst2) expressing tumors. , 2002, Bioconjugate chemistry.

[108]  D. Cocchi,et al.  Characterization of new selective somatostatin receptor subtype-2 (sst2) antagonists, BIM-23627 and BIM-23454. Effects of BIM-23627 on GH release in anesthetized male rats after short-term high-dose dexamethasone treatment. , 2002, Endocrinology.

[109]  G. Hennig,et al.  Somatostatin sst(2) receptors inhibit peristalsis in the rat and mouse jejunum. , 2002, American journal of physiology. Gastrointestinal and liver physiology.

[110]  D. Hoyer,et al.  Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806 , 2002, Naunyn-Schmiedeberg's Archives of Pharmacology.

[111]  B. Ross,et al.  Thyroid hormone-responsive pituitary hyperplasia independent of somatostatin receptor 2. , 2001, Molecular endocrinology.

[112]  J. Reubi,et al.  Localization and characterization of neuropeptide receptors in human colon , 2001, Naunyn-Schmiedeberg's Archives of Pharmacology.

[113]  P. Beck‐Peccoz,et al.  Mutation of somatostatin receptor type 5 in an acromegalic patient resistant to somatostatin analog treatment. , 2001, The Journal of clinical endocrinology and metabolism.

[114]  P. Plas,et al.  Identification of potent non-peptide somatostatin antagonists with sst(3) selectivity. , 2001, Journal of medicinal chemistry.

[115]  J. Rivier,et al.  Potent somatostatin undecapeptide agonists selective for somatostatin receptor 1 (sst1). , 2001, Journal of medicinal chemistry.

[116]  S. Schulz,et al.  Homo- and Heterodimerization of Somatostatin Receptor Subtypes , 2001, The Journal of Biological Chemistry.

[117]  W. Meyerhof,et al.  Agonist‐Mediated Endocytosis of Rat Somatostatin Receptor Subtype 3 Involves β‐Arrestin and Clathrin Coated Vesicles , 2001, Journal of neuroendocrinology.

[118]  T. Pufe,et al.  Influence of the somatostatin receptor sst2 on growth factor signal cascades in human glioma cells. , 2001, Brain research. Molecular brain research.

[119]  Xiaomin Wang,et al.  Cloning and expression of a novel mouse somatostatin receptor ( SSTR 2 B ) , 2001 .

[120]  Y. Wong,et al.  Galpha(14) links a variety of G(i)- and G(s)-coupled receptors to the stimulation of phospholipase C. , 2001, British journal of pharmacology.

[121]  M. Schwaiger,et al.  Comparison of radioiodinated TOC, TOCA and Mtr-TOCA: the effect of carbohydration on the pharmacokinetics , 2001, European Journal of Nuclear Medicine and Molecular Imaging.

[122]  J. Rivier,et al.  SST3-selective potent peptidic somatostatin receptor antagonists. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[123]  P. Rochaix,et al.  Signal transduction of somatostatin receptors negatively controlling cell proliferation , 2000, Journal of Physiology-Paris.

[124]  J. Billard,et al.  Involvement of sst2 somatostatin receptor in locomotor, exploratory activity and emotional reactivity in mice , 2000, The European journal of neuroscience.

[125]  P. Pour,et al.  Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[126]  A. Buchan,et al.  Somatostatin receptor subtype expression and function in human vascular tissue. , 2000, American journal of physiology. Heart and circulatory physiology.

[127]  J. Reubi,et al.  Affinity profiles for human somatostatin receptor subtypes SST1–SST5 of somatostatin radiotracers selected for scintigraphic and radiotherapeutic use , 2000, European Journal of Nuclear Medicine.

[128]  J. Schaeffer,et al.  Somatostatin inhibits insulin and glucagon secretion via two receptors subtypes: an in vitro study of pancreatic islets from somatostatin receptor 2 knockout mice. , 2000, Endocrinology.

[129]  D. Hoyer,et al.  Cloning, expression and pharmacological characterisation of the mouse somatostatin sst(5) receptor. , 2000, Neuropharmacology.

[130]  W. Meyerhof,et al.  Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs , 1999, FEBS letters.

[131]  D. Hoyer,et al.  Characterisation of human recombinant somatostatin receptors. 1. Radioligand binding studies , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[132]  D. Hoyer,et al.  Characterisation of human recombinant somatostatin receptors. 4. Modulation of phospholipase C activity , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[133]  D. Hoyer,et al.  Characterisation of human recombinant somatostatin receptors. 3. Modulation of adenylate cyclase activity , 1999, Naunyn-Schmiedeberg's Archives of Pharmacology.

[134]  P. Emson,et al.  Visualisation of somatostatin receptor sst(3) in the rat central nervous system. , 1999, Brain research. Molecular brain research.

[135]  J. Laissue,et al.  Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous systems of the human gastrointestinal tract: facts and artifacts. , 1999, The Journal of clinical endocrinology and metabolism.

[136]  Y. Patel.  Somatostatin and Its Receptor Family , 1999, Frontiers in Neuroendocrinology.

[137]  A. Tashjian,et al.  Identification of distinct signalling pathways for somatostatin receptors SSTR1 and SSTR2 as revealed by microphysiometry. , 1999, Cellular signalling.

[138]  J. Taylor,et al.  Highly potent cyclic disulfide antagonists of somatostatin. , 1999, Journal of medicinal chemistry.

[139]  P. Rochaix,et al.  Gene therapy for pancreatic carcinoma: local and distant antitumor effects after somatostatin receptor sst2 gene transfer. , 1999, Human gene therapy.

[140]  D. Noonan,et al.  Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[141]  S. Schulz,et al.  Selective targeting of somatostatin receptor 3 to neuronal cilia , 1999, Neuroscience.

[142]  A. Michel,et al.  Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO‐K1 cells and involvement of Gαs proteins , 1999, British journal of pharmacology.

[143]  P. Hayry,et al.  Differential regulation of somatostatin receptor types 1–5 in rat aorta after angioplasty , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[144]  W. Woodmansee,et al.  Cloning of the mouse somatostatin receptor subtype 5 gene: promoter structure and function. , 1999, Endocrinology.

[145]  J. Reubi,et al.  Expression of somatostatin receptors in peritumoral veins of human tumors , 1999, Cancer.

[146]  H. Yao,et al.  Somatostatin activation of mitogen-activated protein kinase via somatostatin receptor 1 (SSTR1). , 1999, Molecular endocrinology.

[147]  R. Houghten,et al.  A linear hexapeptide somatostatin antagonist blocks somatostatin activity in vitro and influences growth hormone release in rats. , 1998, Molecular Pharmacology.

[148]  C. Tang,et al.  Nonpeptide somatostatin agonists with sst4 selectivity: synthesis and structure-activity relationships of thioureas. , 1998, Journal of medicinal chemistry.

[149]  R G Smith,et al.  Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. , 1998, Science.

[150]  J. Laissue,et al.  Immunohistochemical localization of somatostatin receptor sst2A in human pancreatic islets. , 1998, The Journal of clinical endocrinology and metabolism.

[151]  E. Kidd,et al.  Molecular cloning and functional characterization of a rat somatostatin sst2(b) receptor splice variant , 1998, British journal of pharmacology.

[152]  B H Arison,et al.  Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[153]  H. Wilkinson,et al.  High basal gastric acid secretion in somatostatin receptor subtype 2 knockout mice. , 1998, Gastroenterology.

[154]  D. Hoyer,et al.  [125I]Tyr10-cortistatin14 labels all five somatostatin receptors , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[155]  J. Epelbaum,et al.  Characterization of Somatostatin Receptor Subtypes in Mammalian Pituitary , 1998, Annals of the New York Academy of Sciences.

[156]  W. Meyerhof,et al.  Cloning, Expression, Pharmacology and Tissue Distribution of the Mouse Somatostatin Receptor Subtype 5 , 1998, Journal of neuroendocrinology.

[157]  J. Taylor,et al.  Potent antagonists of somatostatin: synthesis and biology. , 1998, Journal of medicinal chemistry.

[158]  J. Epelbaum,et al.  Somatostatin receptor subtypes sst1 and sst2 elicit opposite effects on the response to glutamate of mouse hypothalamic neurones: an electrophysiological and single cell RT‐PCR study , 1998, The European journal of neuroscience.

[159]  W. Meyerhof.  The elucidation of somatostatin receptor functions: a current view. , 1998, Reviews of physiology, biochemistry and pharmacology.

[160]  É. Mezey,et al.  Cell specific expression of the sst2A and sst5 somatostatin receptors in the rat anterior pituitary. , 1998, Endocrinology.

[161]  S. Krantic,et al.  Somatostatin increases mitogen‐induced IL‐2 secretion and proliferation of human jurkat T cells via sst3 receptor isotype , 1998, Journal of cellular biochemistry.

[162]  H. Kreienkamp,et al.  Coupling of rat somatostatin receptor subtypes to a G‐protein gated inwardly rectifying potassium channel (GIRK1) , 1997, FEBS letters.

[163]  R. Mangues,et al.  S49 cells endogenously express subtype 2 somatostatin receptors which couple to increase protein tyrosine phosphatase activity in membranes and down-regulate Raf-1 activity in situ. , 1997, Cellular signalling.

[164]  P. Caron,et al.  Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. , 1997, The Journal of clinical endocrinology and metabolism.

[165]  A. Tsutsumi,et al.  Expression of somatostatin receptor subtype 2 mRNA in human lymphoid cells. , 1997, Cellular immunology.

[166]  Roy G. Smith,et al.  Somatostatin receptor subtype 2 knockout mice are refractory to growth hormone-negative feedback on arcuate neurons. , 1997, Molecular endocrinology.

[167]  C. Sternini,et al.  Somatostatin 2A receptor is expressed by enteric neurons, and by interstitial cells of Cajal and enterochromaffin‐like cells of the gastrointestinal tract , 1997, The Journal of comparative neurology.

[168]  W. Meyerhof,et al.  Phosphorylation of Four Amino Acid Residues in the Carboxyl Terminus of the Rat Somatostatin Receptor Subtype 3 Is Crucial for Its Desensitization and Internalization* , 1997, The Journal of Biological Chemistry.

[169]  A. Schally,et al.  Characterization of the antiproliferative signal mediated by the somatostatin receptor subtype sst5. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[170]  N. Diehl,et al.  Isolation and characterization of the gene encoding the type 5 mouse (Mus musculus) somatostatin receptor (msst5). , 1997, Gene.

[171]  P. Dent,et al.  Activation in vitro of somatostatin receptor subtypes 2, 3, or 4 stimulates protein tyrosine phosphatase activity in membranes from transfected Ras-transformed NIH 3T3 cells: coexpression with catalytically inactive SHP-2 blocks responsiveness. , 1997, Molecular endocrinology.

[172]  J. Sutcliffe,et al.  Cloning, mRNA expression, and chromosomal mapping of mouse and human preprocortistatin. , 1997, Genomics.

[173]  H. Vaudry,et al.  Differential Expression of Multiple Somatostatin Receptors in the Rat Cerebellum During Development , 1997, Journal of neurochemistry.

[174]  É. Mezey,et al.  Immunohistochemical Localization of Somatostatin Receptor SST2A in the Rat Pancreas. , 1997, Endocrinology.

[175]  J. Friedman,et al.  Agonist-induced Desensitization, Internalization, and Phosphorylation of the sst2A Somatostatin Receptor* , 1997, The Journal of Biological Chemistry.

[176]  W. Feniuk,et al.  Characterization of human recombinant somatostatin sst5 receptors mediating activation of phosphoinositide metabolism , 1997, British journal of pharmacology.

[177]  N. Vaysse,et al.  sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells. , 1997, Cancer research.

[178]  G. Gillies.  Somatostatin: the neuroendocrine story. , 1997, Trends in pharmacological sciences.

[179]  S. Melmed,et al.  Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. , 1997, The Journal of clinical investigation.

[180]  E. Kidd,et al.  A quantitative autoradiographical study on the distribution of somatostatin sst2 receptors in the rat central nervous system using [125I]-BIM-23027 , 1996, Neuropharmacology.

[181]  M. Cattaneo,et al.  A somatostatin analogue inhibits MAP kinase activation and cell proliferation in human neuroblastoma and in human small cell lung carcinoma cell lines , 1996, FEBS letters.

[182]  M. Pausch,et al.  Identification and characterization of novel somatostatin antagonists. , 1996, Molecular pharmacology.

[183]  D. Hoyer,et al.  Binding properties of somatostatin receptor subtypes. , 1996, Metabolism: clinical and experimental.

[184]  G. Liapakis,et al.  Molecular and functional properties of somatostain receptor subtypes. , 1996, Metabolism: clinical and experimental.

[185]  A. Beaudet,et al.  Localization of the Somatostatin Receptor SST2A in Rat Brain Using a Specific Anti-Peptide Antibody , 1996, The Journal of Neuroscience.

[186]  O. Prospero-Garcia,et al.  A cortical neuropeptide with neuronal depressant and sleep-modulating properties , 1996, Nature.

[187]  G. Capellá,et al.  Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer. , 1996, Cancer research.

[188]  M. Dichter,et al.  Somatostatin receptor subtypes SSTR2 and SSTR5 couple negatively to an L-type Ca2+ current in the pituitary cell line AtT-20 , 1996, Neuroscience.

[189]  A. Fusco,et al.  Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene. , 1996, The Journal of biological chemistry.

[190]  P. Dent,et al.  Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin. , 1996, The Biochemical journal.

[191]  M. Le Romancer,et al.  Messenger RNA expression of somatostatin receptor subtypes in human and rat gastric mucosae. , 1996, Life sciences.

[192]  G. Buell,et al.  Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst1 and sst2, in mouse fibroblast (Ltk−) cells , 1996, British journal of pharmacology.

[193]  Y. Taché,et al.  Intracerebroventricular injection of somatostatin sst5 receptor agonist inhibits gastric acid secretion in rats. , 1996, European journal of pharmacology.

[194]  P. Emson,et al.  Cellular localisation and co-expression of somatostatin receptor messenger RNAs in the human brain. , 1995, Brain research. Molecular brain research.

[195]  H. Niznik,et al.  The somatostatin receptor family. , 1995, Life sciences.

[196]  A. Klibanski,et al.  Somatostatin receptor subtype gene expression in pituitary adenomas. , 1995, The Journal of clinical endocrinology and metabolism.

[197]  A. Beaudet,et al.  Patterns of expression of SSTR1 and SSTR2 somatostatin receptor subtypes in the hypothalamus of the adult rat: relationship to neuroendocrine function , 1995, Neuroscience.

[198]  D. Hoyer,et al.  Classification and nomenclature of somatostatin receptors. , 1995, Trends in pharmacological sciences.

[199]  S. Law,et al.  Somatostatin receptor activation of cellular effector systems. , 1995, Cellular signalling.

[200]  C. B. Srikant,et al.  Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). , 1994, Endocrinology.

[201]  M. Loda,et al.  The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells. , 1994, Molecular endocrinology.

[202]  T. Reisine,et al.  Characterization of cloned human somatostatin receptor SSTR5. , 1994, Molecular pharmacology.

[203]  S. Seino,et al.  Phospholipase C activation and Ca2+ mobilization by cloned human somatostatin receptor subtypes 1–5, in transfected COS‐7 cells , 1994, FEBS letters.

[204]  E. Nishida,et al.  Functional coupling of SSTR4, a major hippocampal somatostatin receptor, to adenylate cyclase inhibition, arachidonate release and activation of the mitogen-activated protein kinase cascade. , 1994, The Journal of biological chemistry.

[205]  D. Barber,et al.  Subtype-specific signaling mechanisms of somatostatin receptors SSTR1 and SSTR2. , 1994, The Journal of biological chemistry.

[206]  L. Mazzucchelli,et al.  Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease. , 1994, Gastroenterology.

[207]  G. Bell,et al.  Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[208]  H. Niznik,et al.  Molecular cloning, functional characterization, and chromosomal localization of a human somatostatin receptor (somatostatin receptor type 5) with preferential affinity for somatostatin-28. , 1994, Molecular pharmacology.

[209]  J. Laissue,et al.  High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor‐host interaction? , 1994, International journal of cancer.

[210]  M. Berelowitz,et al.  Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat. , 1993, Endocrinology.

[211]  U. Studer,et al.  Human kidney as target for somatostatin: high affinity receptors in tubules and vasa recta. , 1993, The Journal of clinical endocrinology and metabolism.

[212]  E. Krenning,et al.  In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. , 1993, Blood.

[213]  D. Hoyer,et al.  Distribution and second messenger coupling of four somatostatin receptor subtypes expressed in brain , 1993, FEBS letters.

[214]  H. Imura,et al.  Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. , 1993, Biochemical and biophysical research communications.

[215]  R. Espinosa,et al.  Human somatostatin receptor genes: localization of SSTR5 to human chromosome 20p11.2. , 1993, Genomics.

[216]  G. Bell,et al.  Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. , 1993, Molecular pharmacology.

[217]  L. Rohrer,et al.  Cloning and characterization of a fourth human somatostatin receptor. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[218]  P. Seeman,et al.  A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin‐14 like peptides , 1993, FEBS letters.

[219]  M. Greenwood,et al.  Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. , 1993, Biochemical and biophysical research communications.

[220]  M. Stoffel,et al.  Human somatostatin receptor genes: localization to human chromosomes 14, 17, and 22 and identification of simple tandem repeat polymorphisms. , 1993, Genomics.

[221]  L. Mahan,et al.  Molecular cloning and expression of a pituitary somatostatin receptor with preferential affinity for somatostatin: 28. , 1992, Molecular pharmacology.

[222]  S. Seino,et al.  Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. , 1992, Molecular endocrinology.

[223]  W. Meyerhof,et al.  Molecular cloning of a somatostatin-28 receptor and comparison of its expression pattern with that of a somatostatin-14 receptor in rat brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[224]  S. Snyder,et al.  Cloning and expression of a rat somatostatin receptor enriched in brain. , 1992, The Journal of biological chemistry.

[225]  C. Saper,et al.  Cloning of a novel somatostatin receptor, SSTR3, coupled to adenylylcyclase. , 1992, The Journal of biological chemistry.

[226]  J. Laissue,et al.  Preferential location of somatostatin receptors in germinal centers of human gut lymphoid tissue. , 1992, Gastroenterology.

[227]  C. Saper,et al.  Differential expression of somatostatin receptor subtypes in brain , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[228]  H. Lübbert,et al.  Expression cloning of a rat brain somatostatin receptor cDNA. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[229]  S. Seino,et al.  Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[230]  S. Law,et al.  Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors. , 1991, The Journal of biological chemistry.

[231]  Bombesin-like peptides in health and disease. Proceedings of an international symposium. October 13-16, 1987, Rome, Italy. A tribute to Vittorio Erspamer, M.D. , 1988, Annals of the New York Academy of Sciences.

[232]  Disease,et al.  Bombesin-like peptides in health and disease , 1988 .

[233]  M. Low,et al.  Cell-specific processing of preprosomatostatin in cultured neuroendocrine cells. , 1987, The Journal of biological chemistry.

[234]  J. Palacios,et al.  Distribution of somatostatin receptors in the human brain: An autoradiographic study , 1986, Neuroscience.

[235]  J. Reubi,et al.  Somatostatin receptors in the adrenal , 1986, Molecular and Cellular Endocrinology.

[236]  G. Arbuthnott,et al.  Different patterns of molecular forms of somatostatin are released by the rat median eminence and hypothalamus , 1985, Neuroscience Letters.

[237]  J. Reubi.  New specific radioligand for one subpopulation of brain somatostatin receptors. , 1985, Life sciences.

[238]  J. Reubi,et al.  Somatostatin Receptors , 1997, Trends in Endocrinology & Metabolism.

[239]  T. Shows,et al.  High-resolution chromosomal localization of human genes for amylase, proopiomelanocortin, somatostatin, and a DNA fragment (D3S1) by in situ hybridization. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[240]  W. Rutter,et al.  Polymorphic human somatostatin gene is located on chromosome 3. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[241]  W. Rutter,et al.  Human somatostatin I: sequence of the cDNA. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[242]  W. Vale,et al.  High affinity binding sites for somatostatin to rat pituitary. , 1982, Biochemical and biophysical research communications.

[243]  C. B. Srikant,et al.  Somatostatin receptors: identification and characterization in rat brain membranes. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[244]  W. Vale,et al.  High affinity binding sites for a somatostatin-28 analog in rat brain. , 1981, Life sciences.

[245]  V. Mutt,et al.  N‐terminally extended somatostatin: The primary structure of somatostatin‐28 , 1980, FEBS letters.

[246]  A. Tashjian,et al.  Characterization of functional receptors for somatostatin in rat pituitary cells in culture. , 1978, The Journal of biological chemistry.

[247]  L. Krulich,et al.  Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro. , 1968, Endocrinology.